What is Pulpdent?
PULPDENT® Corporation is a family-owned entity with a rich history spanning over 70 years, dedicated to the research and manufacturing of advanced dental materials. The company has carved a niche as a leader in bioactive and biomimetic dental solutions. Its flagship product, ACTIVA BioACTIVE, is engineered to mimic the natural properties of teeth, actively promoting apatite formation and forming a chemical bond with tooth structure, thereby offering enhanced protection against decay. Pulpdent's commitment extends beyond product innovation to encompass comprehensive clinical education and a patient-centric approach to dental care.
How much funding has Pulpdent raised?
Pulpdent has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Pulpdent?
The recent major strategic investment, alongside the overall enterprise-level funding context, suggests Pulpdent is poised for significant scaling and further innovation in its specialized field. This capital infusion is likely to fuel advancements in research and development for novel bioactive and biomimetic materials, potentially expanding manufacturing capabilities and market reach. The company's long-standing dedication to quality and patient outcomes positions it for continued growth and leadership in the dental industry.
See full Pulpdent company page
